Mutations	  in	  feline	  coronavirus	  spike	  protein	  cleavage-­activation	  sites	  in	  cats	  with	  FIP	  

Feline	  coronaviruses	  associated	  with	  feline	  infectious	  peritonitis	  have	  
modifications	  to	  spike	  protein	  activation	  sites	  at	  two	  discrete	  positions	  
Beth	  N.	  Licitra1,	  Kelly	  L.	  Sams1,	  Donald	  W.	  Lee2	  and	  Gary	  R.Whittaker1*	  
1	  Department	  of	  Microbiology	  &	  Immunology,	  College	  of	  Veterinary	  Medicine,	  Cornell	  University,	  Ithaca,	  NY,	  USA.	  
2	  School	  of	  Chemical	  &	  Biomolecular	  Engineering,	  Cornell	  University,	  Ithaca,	  NY,	  USA.	  

*	  corresponding	  author.	  C4	  127	  Veterinary	  Medical	  Center,	  930	  Campus	  Rd,	  Ithaca	  NY	  14853;	  grw7@cornell.edu	  
Abstract.	  Feline	  infectious	  peritonitis	  (FIP)	  is	  associated	  with	  mutations	  in	  the	  feline	  coronavirus	  (FCoV)	  genome	  
that	   are	   thought	   to	   convert	   the	   subclinical	   feline	   enteric	   coronavirus	   (FECV)	   into	   the	   lethal	   feline	   infectious	  
peritonitis	  virus	  (FIPV).	  A	  key	  feature	  of	  FIPV,	  not	  shared	  with	  FECV,	  is	  the	  productive	  infection	  of	  macrophages.	  
Therefore	   mutations	   in	   proteins	   that	   govern	   cell	   tropism,	   such	   as	   the	   spike	   glycoprotein,	   may	   play	   an	   important	  
role	  in	  FIP	  progression.	  	  In	  a	  prior	  study,	  involving	  a	  limited	  number	  of	  samples,	  we	  have	  shown	  an	  association	  of	  
FIP	   with	   mutations	   in	   the	   protease	   cleavage-­‐activation	   site	   located	   between	   the	   receptor-­‐binding	   and	   fusion	  
domains	  of	  the	  FCoV	  spike	  (S1/S2).	  Here,	  we	  extend	  these	  studies	  to	  investigate	  a	  larger	  sample	  set	  and	  to	  obtain	  a	  
more	  refined	  analysis	  of	  the	  mutations	  at	  this	  S1/S2	  site.	  Our	  larger	  data	  set	  more	  clearly	  shows	  that	  the	  mutations	  
acquired	  by	  FIPV	  at	  S1/S2	  are	  also	  accompanied	  by	  additional	  mutations	  at	  a	  second	  protease	  cleavage-­‐activation	  
site	  located	  in	  the	  fusion	  domain	  (S2’),	  adjacent	  to	  the	  viral	  fusion	  peptide.	  Overall,	  our	  data	  indicate	  a	  pattern	  of	  
mutations	   across	   the	   two	   protease	   recognition	   sites	   that	   results	   in	   substitutions,	   and/or	   altered	   recognition,	   of	  
critical	   basic/polar	   amino	   acid	   residues	   needed	   for	   virus	   activation	   in	   the	   enteric	   tract.	   Typically,	   FIPVs	   have	  
substitutions	   of	   non-­‐polar,	   aliphatic	   or	   aromatic	   residues	   in	   the	   protease	   recognition	   sites.	   These	   changes	   likely	  
modulate	  the	  proteolytic	  activation	  of	  the	  virus	  and	  its	  ability	  to	  productively	  infect	  macrophages	  in	  vivo.	  
Introduction	  
Feline	   infectious	   peritonitis	   (FIP)	   is	   a	   fatal	   infection	   of	  
cats	   caused	   by	   a	   feline	   coronavirus	   (FCoV)	   (11).	   FCoV	  
infections	   are	   common,	   especially	   in	   high-­‐density	  
housing	   situations	   such	   as	   animal	   shelters	   and	  
breeding	   facilities.	   	   There	   are	   two	   biotypes	   of	   FCoV,	  
classified	   as	   either	   feline	   enteric	   coronavirus	   (FECV)	   or	  
feline	   infectious	   peritonitis	   virus	   (FIPV).	   The	   biotypes	  
differ	   based	   on	   the	   severity	   of	   infection	   in	   cats.	  
Typically,	   the	   FECV	   biotype	   of	   FCoV	   transmits	   readily	  
via	   the	   fecal-­‐oral	   route,	   infects	   enterocytes	   in	   the	  
gastrointestinal	   tract	   of	   cats,	   and	   causes	   only	   a	   mild	  
infection.	   If	   the	   viral	   infection	   worsens	   and	   becomes	  
systemic	   and	   lethal,	   then	   the	   virus	   is	   classified	   as	   the	  
FIPV	   biotype.	   Symptoms	   associated	   with	   the	   FIPV	  
biotype	   infection	   are	   granulomatous	   lesions,	   vascular	  
leakage,	   and/or	   pleural	   and	   peritoneal	   effusion.	   The	  
current	  understanding	  is	  that	  FIPV	  arises	  during	   in	  vivo	  
infection	  due	  to	  genetic	  mutations	  of	  FECV	  (13,	  23,	  26,	  
36).	   In	   approximately	   1-­‐5%	   of	   enteric	   infections,	   such	  
spontaneous	   “internal	   mutation(s)”	   extend	   FCoV	  
tropism	   to	   include	   blood	   monocytes	   and	   tissue	  
macrophages	   (20).	   The	   resulting	   productive	   infection	  
of	   these	   cells,	   a	   hallmark	   of	   FIP,	   enables	   systemic	  
spread	   and	   results	   in	   macrophage	   activation,	   with	  
concomitant	   immune-­‐mediated	   events	   leading	  
ultimately	   to	   death.	   To	   date,	   the	   precise	   mutation(s)	  
that	   account	   for	   a	   shift	   in	   the	   FCoV	   biotype	   have	   not	  
	  

been	  identified	  and	  there	  is	  no	  definitive	  diagnostic	  test	  
for	   FIP,	   except	   through	   post-­‐mortem	   histopathological	  
analysis	  by	  immunocytochemistry.	  
In	   addition	   to	   the	   two	   different	   biotypes	   (FECV	   and	  
FIPV),	   two	   FCoV	   serotypes	   have	   been	   identified.	  
Serotype	  1	  FCoVs	  are	  highly	  prevalent	  clinically	  (3,	  14,	  
33),	   but	   do	   not	   propagate	   in	   cell	   culture	   and	   are	  
therefore	   studied	   less	   often	   than	   serotype	   2	   FCoVs,	  
which	  are	  easily	  propagated	  in	  vitro	  but	  not	  as	  clinically	  
prevalent.	   In	   this	   study,	   we	   chose	   to	   study	   FECV	   and	  
FIPV	  from	  serotype	  I	  FCoV.	  	  
The	  FCoV	  genome	  is	  approximately	  29	  kB	  with	  11	  open	  
reading	   frames	   encoding	   replication,	   structural,	   and	  
accessory	   proteins	   (15).	   Like	   other	   RNA	   viruses,	  
coronavirus	   replication	   is	   error	   prone,	   with	   an	  
estimated	   mutation	   rate	   of	   approximately	   4×10-­‐4	  
nucleotide	  substitutions/site/year	  (31,	  37).	  It	  has	  been	  
suggested	   that	   mutations	   in	   the	   spike	   protein	   (S),	   3c,	  
and/or	   7b	   genes	   are	   associated	   with	   the	   transition	   of	  
FECV	   to	   FIPV	   (1,	   5-­‐7,	   19,	   22,	   24,	   28).	   Since	   the	   FCoV	  
spike	   protein	   mediates	   receptor	   binding	   (through	   the	  
S1	   subunit)	   and	   fusion	   (through	   the	   S2	   subunit),	   and	  
mutations	   in	   the	   S	   gene	   allowed	   FCoV	   to	   infect	  
macrophages	   (30),	   we	   focused	   on	   correlating	  
mutations	   in	   this	   S	   gene	   with	   the	   biotype	   switch	   and	  
changes	  in	  cellular	  tropism.	  	  
The	   coronavirus	   spike	   protein	   (S)	   is	   a	   class	   I	   fusion	  
protein,	   which	   typically	   requires	   activation	   by	   cellular	  
1	  

Mutations	  in	  feline	  coronavirus	  spike	  protein	  cleavage-­activation	  sites	  in	  cats	  with	  FIP	  

proteases	  to	  be	  able	  to	  mediate	  cell	  entry.	  Mutation	  of	  
the	   proteolytic	   cleavage	   sites	   can	   have	   profound	  
implications	   for	   disease	   progression	   (4,	   16),	   and	  
therefore	   we	   sought	   to	   determine	   whether	   mutations	  
at	   protease	   cleavage	   sites	   are	   evident	   in	   the	   FIPV	  
biotype.	  	  
Proteases	  cleave	  their	  substrates	  though	  recognition	  of	  
specific	   amino	   acid	   motifs	   within	   the	   relative	   position	  
designation	   P6-­‐…-­‐P1	   |	   P1’-­‐…-­‐P6’,	   where	   cleavage	  
occurs	   at	   the	   P1	   position,	   adjacent	   to	   the	   P1’	   position	  
(27).	   In	   this	   paper,	   we	   will	   denote	   the	   cleavage	   site	  
between	   P1	   and	   P1’	   using	   the	   vertical	   bar	   “|”	   symbol.	  
For	   a	   typical	   serine	   protease	   like	   trypsin,	   there	   is	   a	  
strong	  requirement	  for	  a	  basic	  amino	  acid	  (Arg	  or	  Lys)	  
at	  the	  P1	  cleavage	  position.	  Substrate	  residues	  flanking	  
P1	   can	   also	   have	   major	   impacts	   on	   the	   rate	   and	  
specificity	  of	  cleavage	  for	  a	  given	  protease;	  in	  the	  case	  
of	   influenza,	   the	   addition	   of	   arginine/lysine	   residues	  
upstream	   of	   the	   P1	   residue	   (the	   polybasic	   region)	   of	  
the	  viral	  HA	  can	  allow	  an	  alternate	  protease	  called	  furin	  
to	   cleave	   HA	   and	   increase	   the	   virulence	   of	   this	   virus	  
(25).	  	  
Until	   recently,	   FCoVs	   were	   thought	   to	   use	   uncleaved	   S	  
proteins	   to	   enter	   cells.	   However,	   a	   functional	   furin	  
cleavage	   site	   has	   been	   identified	   in	   two	   examples	   of	  
serotype	   1	   FECVs,	   located	   at	   the	   boundary	   of	   the	   S1	  
and	   S2	   subunits	   (9).	   Furin	   is	   a	   ubiquitous	   proprotein	  
convertase	   (PC)	   enriched	   in	   the	   trans-­‐Golgi	   network	  
and	   is	   well	   conserved	   among	   mammals	   (32).	   Furin	  
cleaves	   a	   wide	   range	   of	   protein	   precursors	   into	  
biologically	   active	   products	   at	   a	   consensus	   motif	   that	   is	  
often	   defined	   as	   R-­‐X-­‐K/R-­‐R,	   where	   R	   is	   the	   basic	  
arginine	   residue,	   X	   is	   any	   residue,	   and	   K	   is	   the	   basic	  
lysine	   residue	   (35).	   The	   minimum	   requirement	   for	  
furin	  cleavage	  is	  for	  a	  P1	  and	  P4	  arginine.	  In	  addition	  to	  
the	  P1-­‐P4	  arginines,	  these	  residues	  are	  often	  flanked	  by	  
serine	   residues,	   and	   promoted	   by	   the	   presence	   of	   a	  
basic	   residue	   at	   P2.	   The	   general	   cleavage	   requirement	  
for	   a	   PC	   enzyme	   is	   defined	   as	   cleavage	   at	   paired	   basic	  
residues	   (B-­‐X2n-­‐B),	   where	   the	   intermediate	   residues	   (-­‐
X2n-­‐)	  consist	  of	  0,	  2,	  or	  4	  amino	  acids	  (32).	  
For	   many	   enveloped	   viruses,	   protease	   cleavage	   occurs	  
adjacent	   to	   the	   fusion	   peptide	   site,	   which	   is	   located	   at	  
the	   boundary	   of	   the	   receptor-­‐binding	   and	   fusion	  
domains	  of	  the	  envelope	  protein.	  For	  coronaviruses	  the	  
fusion	  peptide	  is	  located	  within	  the	  fusion	  domains,	  in	  
close	   proximity	   to	   second	   processing	   site	   denoted	   as	  
S2’.	   The	   actual	   proteases	   that	   cleave	   at	   this	   site	   are	  
currently	   unknown,	   but	   may	   include	   members	   of	   the	  
cathepsin	   family	   that	   function	   in	   endosomes	   and	  
lysosomes.	   Mutations	   at	   the	   S2’	   cleavage	   site	   could	   be	  
	  

important	   and	   therefore	   we	   have	   chosen	   to	   study	   this	  
site	  in	  addition	  to	  the	  S1/S2	  cleavage	  site.	  In	  this	  work,	  
we	  used	  an	  approach	  to	  studying	  FIP	  that	  complements	  
and	   extends	   previous	   work.	   We	   focused	   on	   sequence	  
analysis	   of	   the	   two	   cleavage-­‐activation	   sites	   of	   the	  
spike	   gene	   (S1/S2	   and	   S2’),	   which	   are	   functionally	  
relevant	  regions	  for	  virus	  entry	  and	  infection.	  To	  obtain	  
FECV	   gene	   samples,	   fecal	   material	   from	   healthy	   cats	  
that	  carried	  FCoV	  was	  sequenced	  for	  the	  S	  gene.	  These	  
gene	   samples	   were	   operationally	   defined	   as	   being	   from	  
the	  FECV	  biotype,	  and	  56	  FECV	  samples	  were	  obtained	  
in	   this	   study.	   To	   obtain	   FIPV	   samples,	   tissue	   and	   body	  
fluid	   samples	   were	   collected	   from	   cats	   that	   were	  
diagnosed	   with	   FIP.	   For	   tissue	   samples,	   cats	   were	  
typically	   euthanized	   based	   on	   a	   clinical	   diagnosis	   of	  
FIP,	   and	   samples	   were	   collected	   post-­‐euthanasia.	   In	  
many	   cases,	   a	   diagnosis	   of	   FIP	   was	   reconfirmed	   by	  
immunohistochemistry	   (IHC)	   of	   tissue	   from	   the	  
euthanized	  cats,	  but	  not	  all	  samples	  were	  examined	  by	  
IHC	   for	   logistical	   reasons.	   Viral	   gene	   sequences	  
obtained	   from	   FIP	   cats	   were	   operationally	   defined	   as	  
being	   from	   the	   FIPV	   biotype.	   In	   this	   study,	   84	   FIPV	  
samples	   were	   sequenced	   from	   39	   cats	   and	   various	  
organs	   and	   tissues.	   Samples	   from	   our	   previous	   study	  
(19)	   were	   also	   included	   to	   provide	   as	   complete	   a	   data	  
set	   as	   possible,	   and	   we	   compared	   our	   data	   to	   those	   of	   a	  
separate	   study	   by	   Chang	   et	   al.	   (6).	   Our	   studies	   were	  
consistent	   with	   the	   hypothesis	   that	   mutations	   in	   both	  
the	  S1/S2	  and	  S2’	  protease	  cleavage	  sites	  were	  present	  
in	  FIPV	  samples.	  	  
Methods	  
FCoV	   sample	   acquisition	   and	   sequence	   analysis.	   Fecal	  
samples	   from	   subclinically	   infected	   cats	   and	   tissue	  
samples	  from	  cats	  with	  a	  clinical	  diagnosis	  of	  FIP	  were	  
solicited	   from	   shelters,	   breeders	   and	   veterinarians	  
throughout	   the	   United	   States.	   To	   initially	   confirm	  
samples	   were	   FCoV-­‐positive,	   RNA	   was	   extracted	   using	  
QIAamp	   Viral	   RNA	   Mini	   (Qiagen,	   Valencia,	   CA)	   and	  
FCoV	  primers	  that	  detect	  most	  circulating	  strains	  were	  
used	   to	   screen	   all	   fecal	   samples	   using	   the	   procedure	  
outlined	   by	   Herrewegh	   and	   coworkers	   (12).	   RNA	  
extracted	   from	   the	   FIPV-­‐TN406/Black	   lab-­‐adapted	  
strain	   was	   used	   as	   positive	   control.	   Fresh	   tissue	  
samples	   from	   FIP-­‐diagnosed	   cats	   were	   harvested	   and	  
RNA	   samples	   were	   extracted	   using	   MagMAX	   Express	  
(Life	  Technologies,	  Grand	  Island,	  NY).	  
For	  all	  samples	  that	  were	  FCoV-­‐positive,	  50	  μL	  RT-­‐PCR	  
reactions	   were	   performed	   with	   One-­‐Step	   RT-­‐PCR	  
(Qiagen,	   Valencia,	   CA)	   using	   gene-­‐specific	   S	   primers,	  
encompassing	  S1/S2	  and	  S2’:	  S1/S2	  primer	  pair	  
2	  

Mutations	  in	  feline	  coronavirus	  spike	  protein	  cleavage-­activation	  sites	  in	  cats	  with	  FIP	  

5'-­GCACAAGCAGCTGTGATTA-­‐3'	  
and	  
5'-­
GTAATAGAATTGTGGCAT-­3';	   S2'	   primer	   pair	   5'-­
GATATGATCACAGTATCAGATCG	   -­3'	   and	   5'-­‐ATAATC	  
ATCATCAACAGTGCC-­3'.	   PCR	   conditions	   were:	   30	   min	  
at	  50°C,	  15	  min	  at	  95°C,	  and	  39	  or	  35	  cycles	  of:	  1	  min	  at	  
94°C,	   1	   min	   at	   55°C,	   1	   or	   1.5	   min	   at	   72°C,	   10	   min	   at	  
72°C.	   PCR	   products	   were	   purified	   using	   Qiaquick	   Gel	  
Extraction	   (Qiagen,	   Valencia,	   CA).	   Sanger-­‐based	   di-­‐
deoxy	   sequencing	   was	   performed	   at	   the	   Life	   Sciences	  
Core	  Laboratories	  (Cornell	  University).	  DNA	  sequences	  
were	  translated	  into	  protein	  sequences	  and	  alignments	  
were	  
performed	  
using	  
Geneious	  
5.4	  
(http://www.geneious.com).	  
Visual	   Representation	   of	   Mutation	   Data.	   	   	   To	   visualize	  
the	  biochemical	  changes	  in	  the	  protease	  cleavage	  sites	  
of	  the	  S	  protein,	  we	  developed	  a	  specialized	  scatter	  plot	  
through	  MATLAB	  [MathWorks,	  Natick,	  MA].	  A	  separate	  
plot	   was	   made	   for	   each	   residue	   position	   being	  
evaluated,	   and	   the	   Van	   der	   Waals	   (VdW)	   volume	   of	  
amino	  acids	  (29)	  was	  plotted	  against	  their	  hydropathy	  
index	   (HPI)	   (18).	   In	   general,	   amino	   acids	   with	   lower	  
HPI	   are	   more	   hydrophilic	   whereas	   those	   with	   higher	  
HPI	   are	   more	   hydrophobic.	   Each	   data	   point	  
corresponds	   to	   an	   amino	   acid	   that	   was	   found	   at	   the	  
residue	   position	   being	   evaluated,	   and	   the	   size	   of	   the	  
data	   point	   scales	   with	   the	   frequency	   of	   occurrence	   of	  
that	  amino	  acid	  within	  a	  data	  set.	  We	  caution	  here	  that	  
the	   data	   point	   size	   does	   not	   denote	   an	   error	   range	   in	  
VdW	  volume	  or	  HPI.	  Other	  important	  properties	  of	  the	  
amino	   acids	   were	   portrayed	   by	   color-­‐coding	   the	   data	  
points	   as	   such:	   polar	   positive	   (blue:	   H,K,R),	   polar	  
negative	   (red:	   D,E),	   polar	   neutral	   (green:	   S,T,N,Q),	  
nonpolar	  aliphatic	  (gray:	  A,V,L,I,M),	  nonpolar	  aromatic	  
(magenta:	   F,W,Y),	   unique	   (brown:	   P,G),	   and	   disulfide	  
bond-­‐forming	  (cyan:	  C).	  	  

study,	   we	   also	   noted	   a	   high	   degree	   of	   conservation	   at	  
the	   P6	   cleavage	   position	   (which	   can	   be	   highly	  
important	   for	   furin	   cleavage).	   All	   samples	   contained	   a	  
polar	  uncharged	  residue	  (S,	  T	  or	  Q)	  at	  the	  P6	  position.	  
Overall,	   the	   expanded	   data	   set	   reinforces	   the	   notion	  
that	   the	   S1/S2	   motif	   is	   cleaved	   by	   furin.	   Based	   on	   the	  
data	   from	   this	   study,	   we	   consider	   to	   following	   as	   an	  
“FECV”	  motif	  at	  the	  S1/S2	  position:	  -­‐S/T/Q-­‐R-­‐R-­‐S/A-­‐R-­‐
R-­‐S-­‐	  
At	  the	  S2’	  site,	  the	  conserved	  nature	  of	  the	  FCoV	  fusion	  
peptide	   (SAVEDLLF)	   was	   readily	   apparent,	   along	   with	  
the	   expected	   conserved	   arginine	   residue	   in	   the	   P1	  
cleavage	   position	   (Table	   1).	   All	   FECV	   samples	   tested	  
contained	   a	   P2	   lysine,	   with	   the	   high	   level	   of	  
conservation	   implicating	   this	   as	   a	   functionally	   critical	  
residue.	  The	  P1’	  residue	  (S)	  was	  also	  100%	  conserved,	  
consistent	  with	  a	  role	  in	  protease	  cleavage,	  as	  well	  as	  in	  
fusion	  peptide	  function.	  Overall,	  we	  found	  an	  invariant	  
motif	   -­‐K-­‐R-­‐S-­‐	   at	   the	   S2’	   position	   of	   FECV,	   and	   the	  
dibasic	  nature	  of	  this	  site	  is	  consistent	  with	  cleavage	  by	  
a	   range	   of	   proteases,	   including	   non-­‐furin	   PCs	   and	  
cathepsin	  B.	  
FIPV	  sequence	  from	  FIP	  cats	  
The	   amino	   acid	   sequence	   motifs	   for	   the	   S1/S2	   and	   S2’	  
regions	  in	  the	  FCoV	  spike	  gene	  amplified	  from	  various	  
tissues	   and	   body	   fluid	   samples	   are	   shown	   in	   Table	   2.	  
For	  S1/S2,	  the	  FECV	  motif	  -­‐S/T/Q-­‐R-­‐R-­‐S/A-­‐R-­‐R-­‐S-­‐	  was	  
disrupted	   in	   the	   vast	   majority	   of	   samples.	   In	   addition,	  
the	   S2’	   FECV	   -­‐K-­‐R-­‐S-­‐	   motif	   was	   disrupted	   in	   many	  
samples.	   Fecal	   material	   from	   FIP	   cats	   is	   shown	   in	   Table	  
3,	  with	  sequences	  very	  similar	  to	  FECV	  samples.	  
For	   S1/S2,	   we	   focused	   our	   analysis	   on	   the	   “core”	  
residues	   for	   furin	   cleavage,	   i.e.	   the	   P1’,	   P1,	   P2	   and	   P4	  
residues.	  The	  most	  frequent	  substitution	  was	  at	  the	  P1	  
position,	   where	   11	   cats	   displayed	   a	   change	   of	   Arg	   for	  
Gly	  (4	  cats),	  Met	  (4	  cats),	  Trp	  (2	  cats),	  Thr	  (1	  cat)	  and	  
Ser	  (1	  cat).	  The	  next	  most	  frequent	  substitution	  was	  at	  
the	   P2	   position,	   where	   10	   cats	   displayed	   a	   change	   of	  
Arg	  for	  Leu	  (6	  cats),	  Pro	  (3	  cats),	  Ser	  (1	  cat)	  and	  His	  (1	  
cat).	   Five	   cats	   had	   a	   substitution	   at	   the	   P4	   position,	  
which	  displayed	  a	  change	  of	  Arg	  for	  Thr	  (2	  cats)	  Gly	  (1	  
cat),	   Ser	   (1	   cat),	   and	   Met	   (1	   cat).	   Four	   cats	   had	   a	  
substitution	   at	   the	   P1’	   position,	   which	   displayed	   a	  
change	   of	   Ser	   for	   Ala	   (2	   cats)	   Pro	   (1	   cat),	   Gly	   (1	   cat),	  
and	   Leu	   (1	   cat).	   	   All	   of	   these	   changes	   in	   the	   core	  
residues	   would	   be	   expected	   to	   be	   highly	   functionally	  
significant	  for	  furin	  cleavage.	  
At	   the	   S2’,	   the	   conserved	   nature	   of	   the	   fusion	   peptide	  
(SAVEDLLF)	  was	  again	  readily	  apparent,	  along	  with	  an	  
invariant	   Ser	  at	  the	  P1’	  position	   (Table	  2).	  While	  most	  

Results	  and	  Discussion	  
FECV	  sequence	  from	  healthy	  cats	  
The	   amino	   acid	   sequence	   motifs	   for	   the	   S1/S2	   and	   S2’	  
regions	   are	   shown	   in	   Table	   1.	   	   For	   the	   S1/S2	   site,	   the	  
previously	   recognized	   motif	   -­‐R-­‐R-­‐S/A-­‐R-­‐R-­‐S-­‐	   (19)	   was	  
again	  found	  to	  be	  highly	  conserved.	  There	  was	  a	  limited	  
variability	  in	  the	  P5	  position,	  with	  Arg	  substituted	  for:	  
Gly	  (1	  cat)	  and	  Lys	  (1	  cat).	  The	  functional	  relevance	  of	  
this	   variation	   is	   unclear,	   though	   the	   P5	   position	   is	   not	  
generally	   considered	   to	   be	   highly	   important	   for	   furin	  
cleavage.	  There	  was	  also	  a	  single	  case	  with	  a	  change	  in	  
the	   P3	   position	   with	   Ser/Ala	   substituted	   for	   Val	   (1	   cat).	  
As	   with	   P5,	   the	   type	   of	   amino	   acid	   residue	   at	   the	   P3	  
position	   is	   not	   functionally	   critical	   for	   furin	   cleavage.	  
Based	   on	   the	   expanded	   dataset	   available	   from	   this	  
	  

3	  

Mutations	  in	  feline	  coronavirus	  spike	  protein	  cleavage-­activation	  sites	  in	  cats	  with	  FIP	  

FIPV	   cats	   contained	   a	   P1	   arginine,	   three	   cats	   had	  
substitutions	   for	   Ser.	   This	   change	   would	   be	   expected	   to	  
be	  highly	  functionally	  significant	  for	  protease	  cleavage.	  
There	  were	  more	  substitutions	  in	  the	  P2	  residue,	  with	  
five	   cats	   displaying	   a	   change	   of	   Lys	   for	   Met	   (3	   cats)	   and	  
Glu	   (2	   cats).	   These	   changes	   would	   also	   be	   expected	   to	  
be	  highly	  functionally	  significant	  for	  protease	  cleavage.	  
The	   overall	   switch	   in	   the	   dibasic	   nature	   of	   the	   S2’	   site	  
in	   some	   cats	   is	   consistent	   with	   a	   change	   in	   the	  
protease(s)	  cleaving	  at	  this	  position.	  
For	   the	   core	   residues	   at	   S1/S2	   and	   S2’.	   31	   out	   of	   39	   FIP	  
cats	   (77%)	   had	   samples	   that	   were	   modified	   from	   the	  
FECV	   consensus	   (-­‐S/T/Q-­‐-­‐R-­‐R-­‐S/A-­‐R-­‐R-­‐S-­‐).	   Healthy	  
cats	  showed	  no	  deviation	  from	  the	  core	  motif	  
The	   P6,	   P5	   and	   P3	   residues	   within	   the	   S1/S2	   site	   (-­‐	  
S/T/Q-­‐-­‐R-­‐R-­‐S/A-­‐R-­‐R-­‐S-­‐)	   were	   defined	   as	   “non-­‐core”	  
residues	   as	   these	   are	   likely	   to	   be	   less	   functionally	  
relevant	  for	  furin	  cleavage.	  Of	  these	  residues,	  P6	  likely	  
impacts	   furin	   cleavage	   the	   most.	   For	   the	   P6	   position,	  
five	   cats	   displayed	   a	   change	   of	   Ser/Thr/Gln	   for	   Pro	   (2	  
cats),	   Phe	   (1	   cats),	   Ala	   (1	   cat)	   and	   Leu	   (1	   cat).	   All	   of	  
these	   changes	   would	   be	   expected	   to	   be	   functionally	  
significant	  for	  furin	  cleavage.	  	  
Including	   S1/S2	   P6	   as	   a	   core	   residue	   revealed	   that	   33	  
out	   of	   39	   FIP	   cats	   (85%)	   had	   samples	   that	   were	  
modified	  from	  the	  FECV	  consensus	  (-­‐S/T/Q-­‐R-­‐R-­‐S/A-­‐R-­‐
R-­‐S-­‐).	   Healthy	   cats	   showed	   no	   deviation	   from	   a	   core	  
motif	  including	  P6.	  
For	  the	  non-­‐core	  S1/S2	  P5	  position,	  nine	  cats	  displayed	  
a	   change	   of	   Arg	   for	   Lys	   (8	   cats),	   as	   seen	   for	   FECV.	   For	  
the	   non-­‐core	   S1/S2	   P3	   position,	   two	   cats	   displayed	   a	  
change	  of	  Ser/Ala	  for	  Met	  (1	  cats)	  and	  Thr	  (1	  cat).	  The	  
significance	  of	  these	  changes	  is	  uncertain.	  The	  S2’	  non-­‐
core	   P1’	   residue	   showed	   no	   deviation	   in	   either	   FIP	   or	  
healthy	  cats.	  
Including	   both	   core	   and	   non-­‐core	   residues	   at	   S1/S2	  
and	   S2’,	   we	   found	   that	   37/39	   FIP	   cats	   (95%)	   had	  
mutations	  compared	  to	  healthy	  cats.	  9%	  of	  healthy	  cats	  
showed	  a	  mutation	  within	  the	  non-­‐core	  residues	  
It	   is	   noteworthy	   that	   many	   cats	   had	   multiple	   changes	  
across	   the	   two	   proteolytic	   cleavage	   sites	   and	   while	  
there	   was	   a	   wide	   variety	   of	   different	   substitutions	  
present	   in	   different	   cats,	   sampling	   of	   multiple	   tissues	  
within	   an	   individual	   cat	   (e.g.	   cat#197)	   revealed	  
relatively	   limited	   variation.	   It	   is	   also	   noteworthy	   that	  
most	   of	   our	   samples	   would	   be	   expected	   to	   be	  
comprised	   of	   “end-­‐stage”	   viruses,	   where	   cats	   have	  
more	  obvious	  clinical	  signs	  of	  FIP.	  It	  will	  be	  interesting	  
to	   track	   cats	   that	   might	   be	   in	   an	   “early”,	   possibly	   sub-­‐
clinical,	   phase	   of	   FIP.	   These	   cats	   may	   harbor	   viruses	  
	  

that	   have	   different	   mutations	   to	   end-­‐stage	   viruses	  
sampled	  here,	  in	  particular	  in	  the	  “non-­‐core”	  residues.	  
While	  a	  prediction	  of	  the	  proteases	  coming	  into	  play	  for	  
FIPV	  is	  quite	  uncertain,	  the	  trend	  in	  our	  data	  is	  for	  the	  
replacement	   of	   critical	   basic	   residues	   and	   serine	   with	  
more	   hydrophobic	   residues,	   a	   pattern	   consistent	   with	  
cleavage	   by	   an	   alternative	   protease(s).	   Such	   proteases	  
may	   include	   cathepsins	   (8),	   or	   matrix	   metalloproteases	  
(MMPs)	  (17).	  MMPs	  are	  known	  to	  be	  highly	  expressed	  
on	   macrophages	   (2)	   and	   to	   our	   knowledge,	   MMP-­‐
mediated	   cleavage	   of	   a	   viral	   envelope	   protein	   would	   be	  
unique	  situation	  for	  a	  virus	  entry	  pathway.	  Both	  MMPs	  
and	   cathepsin	   demonstrate	   relatively	   broad	   substrate	  
specificity,	   in	   line	   with	   the	   range	   of	   mutations	   seen	   in	  
the	  cleavage	  site(s)	  of	  FIPVs.	  
Comparison	  to	  a	  separate	  study	  (Chang	  et.	  al.	  2012)	  
and	  to	  database	  sequences	  
The	  data	  generated	  during	  the	  course	  of	  our	  study	  was	  
compared	   to	   that	   generated	   by	   a	   separate	   study,	   Chang	  
et	   al.	   2012	   (6),	   as	   well	   as	   to	   additional	   database	  
sequences	   (Table	   4).	   For	   S1/S2,	   of	   the	   ten	   FECV	  
sequences	   in	   Chang	   et	   al.,	   the	   -­‐Q/R/S-­‐R-­‐R-­‐S/A-­‐R-­‐R-­‐S-­‐	  
motif	   was	   preserved	   with	   one	   exception,	   where	   one	   cat	  
had	   a	   P6	   Pro	   residue.	   All	   core	   residues	   were	   identical	  
to	   our	   study.	   A	   P6	   Pro	   was	   also	   found	   in	   one	   other	  
database	   sequence.	   The	   pattern	   of	   residues	   in	   FIPV	  
samples	   followed	   the	   same	   general	   pattern	   as	  
described	   for	   our	   study;	   i.e.	   introduction	   of	   non-­‐polar,	  
aliphatic	   or	   aromatic	   residues	   in	   the	   protease	  
recognition	   sites.	   	   Of	   the	   eleven	   FIP	   cats	   samples	   in	  
Chang	  et	  al.	  2012,	  four	  had	  P1	  substitutions	  (G,	  W	  and	  
S),	   two	   had	   P1’	   substitutions	   (L	   and	   P),	   two	   had	   P4	  
substitutions	  (G	  and	  S),	  and	  three	  had	  P6	  substitutions	  
(L	   and	   P).	   Of	   seven	   database	   samples,	   three	   had	   P1	  
substitutions	   (G,	   W	   and	   S),	   two	   had	   P1’	   substitutions	  
(P),	   one	   had	   P4	   substitutions	   (Q),	   and	   five	   had	   P6	  
substitutions	  (A	  and	  P).	  
At	  S2’,	  Chang	  et	  al.	  2012	  show	  some	  limited	  changes	  of	  
the	   invariant	   KRS	   motif	   for	   FECV,	   with	   different	   P2	  
residues	  in	  four	  cats,	  substituted	  with	  Arg	  (3	  cats)	  and	  
Thr	  (1	  cat).	  Cats	  with	  FIP	  showed	  an	  introduction	  of	  a	  
hydrophobic	   reside	   at	   P2	   in	   five	   cases,	   with	   Lys	   being	  
substituted	   for	   Met	   (4	   cats)	   and	   Val	   (1	   cat).	   A	   similar	  
trend	   was	   present	   in	   database	   samples,	   with	  
introduction	   of	   Val,	   Ala	   and	   Gln	   in	   three	   individual	  
cases.	  
Overall,	   we	   consider	   that	   the	   data	   from	   Chang	   et	   al.	  
2012,	   as	   well	   as	   other	   database	   sequences,	   are	   in	  
strong	  agreement	  with	  the	  data	  from	  this	  study.	  10/11	  
(91%)	   of	   samples	   from	   Chang	   et	   al	   2012.	   and	   4/4	  
4	  

Mutations	  in	  feline	  coronavirus	  spike	  protein	  cleavage-­activation	  sites	  in	  cats	  with	  FIP	  

(100%)	   of	   database	   samples	   had	   functionally	  
significant	  mutations	  in	  the	  spike	  cleavage	  sites.	  
Visual	  representation	  of	  sequences	  in	  the	  protease	  
activation	  sites	  of	  FECV	  and	  FIPV	  spike	  proteins	  
Finding	   a	   mutation	   pattern	   that	   could	   explain	   the	  
transformation	  of	  FECV	  to	  FIPV	  is	  challenging	  because	  
amino	   acids	   have	   multiple	   properties	   that	   are	   similar	  
or	   dissimilar	   with	   each	   other,	   such	   as	   molecular	   size,	  
hydrophobicity,	   and	   charge	   (34).	   In	   order	   to	  
simultaneously	   visualize	   changes	   to	   multiple	  
biochemical	   properties,	   we	   developed	   a	   specialized	  
scatter	   plot	   through	   MATLAB	   that	   shows	   the	   Van	   der	  
Waals	   volume	   (Y-­‐axis),	   hydropathy	   index	   (X-­‐axis),	  
frequency	   of	   occurrence	   (data	   point	   size),	   and	   unique	  
property	   (color	   code)	   of	   amino	   acids	   found	   at	   the	  
cleavage	   site	   positions.	   The	   resulting	   plots	   are	   shown	  
in	   Figure	   1	   for	   the	   residues	   at	   the	   S1/S2	   and	   S2’	  
cleavage	  sites	  for	  both	  the	  FECV	  and	  FIPV	  samples.	  	  
Compared	   to	   FECV,	   FIPV	   contains	   the	   following	  
changes	  in	  the	  S1/S2	  cleavage	  site:	  P6	  and	  P1’	  mutates	  
from	   polar	   neutral	   residues	   to	   nonpolar	   residues,	   P4	  
and	   P2	   mutates	   from	   arginine	   to	   smaller	   and	   more	  
hydrophobic	   residues,	   and	   P1	   mutates	   from	   arginine	   to	  
more	   hydrophobic	   residues.	   At	   the	   S2’	   cleavage	   site,	  
FIPV	   contains	   the	   following	   mutations:	   P2	   mutates	  
from	   positively	   charged	   lysine	   to	   either	   negatively	  
charged	   glutamate	   or	   uncharged	   methionine,	   and	   P1	  
mutates	   from	   positively	   charged	   arginine	   to	   polar	  
neutral	   serine	   that	   is	   half	   the	   volume	   of	   arginine.	   In	  
summary,	   the	   visualization	   of	   biochemical	   changes	   at	  
the	  cleavage	  sites	  using	  our	  plotting	  method	  can	  greatly	  
aid	   with	   the	   identification	   of	   mutation	   patterns	  
associated	  with	  FIP.	  
Potential	  use	  of	  this	  study	  for	  diagnosis	  of	  FIP	  in	  cats	  

We	   believe	   that	   our	   study	   will	   be	   of	   benefit	   in	   the	  
diagnosis	   of	   FIP	   in	   cats	   by	   detecting	   mutations	   in	   S	  
protein	   cleavage	   site	   that	   mimic	   those	   found	   in	   FIPV.	  
However,	  the	  pattern	  of	  variant	  viruses	  seen	  in	  FIP	  cats	  
is	   complex.	   We	   consider	   that	   the	   tracking	   of	   the	   ten	  
amino	   acids	   that	   comprise	   the	   cleavage	   sites	   of	   FCoV	  
spike	   (-­‐S/T/Q-­‐R-­‐R-­‐S/A-­‐R-­‐R-­‐S-­‐	   from	   S1/S2	   and	   -­‐K-­‐R-­‐S-­‐	  
from	   S2’)	   with	   respect	   to	   the	   biochemical	   parameters	  
of	   size,	   hydrophobicity,	   and	   charge	   can	   be	   used	   to	  
predict	   the	   likelihood	   of	   FIP	   in	   cats.	   To	   simplify	   the	  
detection	  of	  FIPV-­‐like	  mutations,	  one	  could	  potentially	  
use	   the	   changes	   in	   these	   biochemical	   parameters	   in	  
conjunction	   with	   a	   ranking	   of	   the	   core	   and	   non-­‐core	  
residues	   to	   arrive	   at	   a	   “FIP	   diagnostic	   score.”	   Such	   a	  
scoring	   system	   could	   help	   clinicians	   identify	   which	   cats	  
are	   likely	   to	   develop	   FIP	   without	   the	   need	   to	  
functionally	  investigate	  every	  mutation	  found.	  The	  use	  
5	  
	  

of	   this	   scoring	   metric	   for	   samples	   that	   clinicians	   can	  
easily	   access	   (e.g.	   blood)	   would	   be	   helpful	   for	  
diagnosing	   FIP	   early	   and	   quickly.	   While	   our	   current	  
study	  only	  utilized	  a	  limited	  number	  of	  blood	  samples,	  
mutations	  consistent	  with	  a	  FIPV	  biotype	  were	  seen	  in	  
all	   positive	   samples.	   However,	   it	   is	   known	   that	   FCoV	  
can	   be	   present	   in	   the	   blood	   monocytes	   of	   healthy	   cats	  
without	  necessarily	  leading	  to	  FIP	  (10,	  12,	  28).	  Further	  
investigation	   into	   the	   spike	   protein	   cleavage	   site	  
changes	  in	  blood	  samples	  of	  both	  healthy	  and	  FIP	  cats	  
will	  form	  a	  future	  focus	  of	  this	  study.	  
We	   considered	   that	   fecal	   samples	   from	   FIP	   cats	   were	  
likely	   to	   be	   contaminated	   with	   an	   ongoing	   infection	  
with	  FECV,	  and	  so	  not	  discriminatory	  for	  FIP.	  This	  was	  
confirmed,	   as	   the	   FIP	   cats	   tested	   in	   this	   study	  
continued	   to	   shed	   FECV-­‐like	   viruses,	   based	   on	   the	  
highly	   limited	   sequence	   variation	   observed	   at	   the	   spike	  
cleavage	  sites	  (Table	  3).	  	  
FIP	   exists	   in	   two	   clinical	   manifestations	   (wet	   and	   dry)	  
(21).	   As	   in	   our	   previous	   study	   (19),	   we	   found	   no	  
correlation	   between	   sequence	   alterations	   at	   the	   spike	  
cleavage	  sites	  between	  “wet”	  and	  “dry”	  FIP	  cats.	  These	  
differences	  in	  clinical	  presentation	  are	  likely	  to	  be	  due	  
to	  immunological	  factors	  in	  individual	  cats,	  rather	  than	  
differences	   in	   the	   cleavage-­‐activation	   of	   the	   viruses	  
infecting	  these	  cats.	  
The	  use	  of	  the	  techniques	  reported	  here	  for	  serotype	  I	  
FCoVs	   may	   also	   be	   applied	   to	   serotype	   II	   FCoVs;	  
however,	  these	  viruses	  lack	  an	  equivalent	  S1/S2	  motif.	  
Investigation	  of	  predictive	  changes	  in	  the	  S2’	  region	  of	  
serotype	  II	  FCoVs	  is	  currently	  ongoing.	  
Acknowledgments	  
We	   thank	   Jean	   Millet,	   Lisa	   Bolin	   and	   members	   of	   the	   Whittaker	  
laboratory,	   Ruth	   Collins,	   Dante	   Lepore	   and	   members	   of	   Collins	  
laboratory,	  and	  Susan	  Daniel	  and	  members	  of	  Daniel	  laboratory	  for	  
advice	  and	  discussion	  during	  the	  course	  of	  this	  study.	  The	  authors	  
also	  thank	  Drs.	  Meredith	  Brown,	  Stephen	  O’Brien,	  Sean	  McDonough,	  
Edward	   Dubovi	   and	   Gerald	   Duhamel	   for	   providing	   some	   of	   the	  
clinical	   samples	   used	   in	   this	   study,	   Andrew	   Regan	   and	   Kirsten	  
Elfers	   for	   initial	   work	   on	   this	   project,	   and	   Nadia	   Chapman,	   Vera	  
Rinaldi,	   Misty	   Pocwiercz,	   Valerie	   Marcano,	   Rod	   Getchell	   and	   Wendy	  
Wingate	   for	   technical	   assistance.	   This	   work	   was	   funded	   in	   part	   by	   a	  
sponsored	   project	   from	   Antech	   Diagnostics.	   B.L.	   was	   supported	   by	  
funds	   from	   the	   Cornell	   University	   College	   of	   Veterinary	   Medicine	  
DVM/PhD	   program.	   Work	   in	   the	   author’s	   lab	   is	   also	   supported	   by	  
grants	   from	   the	   Cornell	   Feline	   Health	   Center,	   the	   Winn	   Feline	  
Health	   Foundation	   and	   the	   Morris	   Animal	   Foundation.	   The	  
sponsors	   had	   no	   influence	   in	   the	   study	   design,	   the	   collection,	  
analysis	  and	  interpretation	  of	  data,	  the	  writing	  of	  the	  manuscript,	  or	  
in	   the	   decision	   to	   submit	   the	   manuscript	   for	   publication.	   All	   work	  
with	   animals	   was	   approved	   by	   the	   Institutional	   Animal	   Use	   and	  
Care	  Committee	  at	  Cornell	  University	  (Ithaca	  NY).	  

Mutations	  in	  feline	  coronavirus	  spike	  protein	  cleavage-­activation	  sites	  in	  cats	  with	  FIP	  

References	  
1.	  
2.	  
3.	  
4.	  
5.	  
6.	  
7.	  
8.	  
9.	  
10.	  
11.	  
12.	  
13.	  
14.	  
15.	  
16.	  
17.	  
18.	  
19.	  
20.	  
	  

Bank-­Wolf,	  B.	  R.,	  I.	  Stallkamp,	  S.	  Wiese,	  A.	  Moritz,	  G.	  Tekes,	  and	  H.	  J.	  Thiel.	  2014.	  Mutations	  of	  3c	  and	  
spike	  protein	  genes	  correlate	  with	  the	  occurrence	  of	  feline	  infectious	  peritonitis.	  Vet	  Microbiol	  173:177-­‐88.	  
Barrett,	   A.	   J.,	   N.	   D.	   Rawlings,	   and	   J.	   F.	   Woessner.	   2004.	   Handbook	   of	   Proteolytic	   Enzymes.	   Elsevier	  
Academic	  Press,	  London.	  
Benetka,	   V.,	   A.	   Kubber-­Heiss,	   J.	   Kolodziejek,	   N.	   Nowotny,	   M.	   Hofmann-­Parisot,	   and	   K.	   Mostl.	   2004.	  
Prevalence	   of	   feline	   coronavirus	   types	   I	   and	   II	   in	   cats	   with	   histopathologically	   verified	   feline	   infectious	  
peritonitis.	  Vet	  Microbiol	  99:31-­‐42.	  
Bosch,	   B.	   J.,	   and	   P.	   J.	   Rottier.	   2008.	   Nidovirus	   Entry	   into	   Cells,	   p.	   157-­‐178.	   In	   S.	   Perlman,	   T.	   Gallagher,	   and	  
E.	  J.	  Snijder	  (ed.),	  Nidoviruses.	  ASM	  Press,	  Washington	  DC.	  
Chang,	  H.	  W.,	  R.	  J.	  de	  Groot,	  H.	  F.	  Egberink,	  and	  P.	  J.	  Rottier.	  2014.	  Feline	  infectious	  peritonitis:	  insights	  
into	  feline	  coronavirus	  pathobiogenesis	  and	  epidemiology	  based	  on	  genetic	  analysis	  of	  the	  viral	  3c	  gene.	  J	  
Gen	  Virol	  91:415-­‐20.	  
Chang,	  H.	  W.,	  H.	  F.	  Egberink,	  R.	  Halpin,	  D.	  J.	  Spiro,	  and	  P.	  J.	  Rottier.	  2012.	  Spike	  protein	  fusion	  peptide	  
and	  feline	  coronavirus	  virulence.	  Emerg	  Infect	  Dis	  18:1089-­‐95.	  
Chang,	   H.	   W.,	   H.	   F.	   Egberink,	   and	   P.	   J.	   Rottier.	   2014.	   Sequence	   analysis	   of	   feline	   coronaviruses	   and	   the	  
circulating	  virulent/avirulent	  theory.	  Emerg	  Infect	  Dis	  17:744-­‐6.	  
Choe,	  Y.,	  F.	  Leonetti,	  D.	  C.	  Greenbaum,	  F.	  Lecaille,	  M.	  Bogyo,	  D.	  Bromme,	  J.	  A.	  Ellman,	  and	  C.	  S.	  Craik.	  
2006.	   Substrate	   profiling	   of	   cysteine	   proteases	   using	   a	   combinatorial	   peptide	   library	   identifies	   functionally	  
unique	  specificities.	  J	  Biol	  Chem	  281:12824-­‐32.	  
de	   Haan,	   C.	   A.	   M.,	   B.	   J.	   Haijema,	   P.	   Schellen,	   P.	   W.	   Schreur,	   E.	   te	   Lintelo,	   H.	   Vennema,	   and	   P.	   J.	   M.	  
Rottier.	  2008.	  Cleavage	  of	  Group	  1	  Coronavirus	  Spike	  Proteins:	  How	  Furin	  Cleavage	  Is	  Traded	  Off	  against	  
Heparan	  Sulfate	  Binding	  upon	  Cell	  Culture	  Adaptation.	  J	  Virol	  82:6078-­‐6083.	  
Gunn-­Moore,	  D.	  A.,	  T.	  J.	  Gruffydd-­Jones,	  and	  D.	  A.	  Harbour.	  1998.	  Detection	  of	  feline	  coronaviruses	  by	  
culture	  and	  reverse	  transcriptase-­‐polymerase	  chain	  reaction	  of	  blood	  samples	  from	  healthy	  cats	  and	  cats	  
with	  clinical	  feline	  infectious	  peritonitis.	  Vet	  Microbiol	  62:193-­‐205.	  
Haijema,	   B.	   J.,	   P.	   J.	   Rottier,	   and	   R.	   J.	   de	   Groot.	   2007.	   Feline	   Coronaviruses:	   A	   Tale	   of	   Two-­‐Faced	   Types,	   p.	  
183-­‐203.	  In	  V.	  Thiel	  (ed.),	  Coronaviruses.	  Molecular	  and	  Cellular	  Biology.	  Caister	  Academic	  Press,	  Norfolk,	  
UK.	  
Herrewegh,	   A.	   A.,	   R.	   J.	   de	   Groot,	   A.	   Cepica,	   H.	   F.	   Egberink,	   M.	   C.	   Horzinek,	   and	   P.	   J.	   Rottier.	   1995.	  
Detection	  of	  feline	  coronavirus	  RNA	  in	  feces,	  tissues,	  and	  body	  fluids	  of	  naturally	  infected	  cats	  by	  reverse	  
transcriptase	  PCR.	  J	  Clin	  Microbiol	  33:684-­‐9.	  
Herrewegh,	   A.	   A.,	   H.	   Vennema,	   M.	   C.	   Horzinek,	   P.	   J.	   Rottier,	   and	   R.	   J.	   de	   Groot.	   1995.	   The	   molecular	  
genetics	   of	   feline	   coronaviruses:	   comparative	   sequence	   analysis	   of	   the	   ORF7a/7b	   transcription	   unit	   of	  
different	  biotypes.	  Virology	  212:622-­‐31.	  
Hohdatsu,	  T.,	  S.	  Okada,	  Y.	  Ishizuka,	  H.	  Yamada,	  and	  H.	  Koyama.	  1992.	  The	  prevalence	  of	  types	  I	  and	  II	  
feline	  coronavirus	  infections	  in	  cats.	  J	  Vet	  Med	  Sci	  54:557-­‐62.	  
King,	  A.	  M.	  Q.,	  E.	  Lefkowitz,	  M.	  J.	  Adams,	  and	  E.	  B.	  Carstens.	  2011.	  Virus	  Taxonomy:	  IXth	  Report	  of	  the	  
International	  Committee	  on	  Taxonomy	  of	  Viruses.	  Elsevier.	  
Klenk,	  H.-­D.,	  and	  W.	  Garten.	  1994.	  Activation	  cleavage	  of	  viral	  spike	  proteins	  by	  host	  proteases,	  p.	  241-­‐
280.	   In	   E.	   Wimmer	   (ed.),	   Cellular	   Receptors	   for	   Animal	   Viruses.	   Cold	   Spring	   Harbor	   Press,	   Cold	   Spring	  
Harbor,	  NY.	  
Kridel,	   S.	   J.,	   E.	   Chen,	   L.	   P.	   Kotra,	   E.	   W.	   Howard,	   S.	   Mobashery,	   and	   J.	   W.	   Smith.	   2001.	   Substrate	  
hydrolysis	  by	  matrix	  metalloproteinase-­‐9.	  J	  Biol	  Chem	  276:20572-­‐8.	  
Kyte,	   J.,	   and	   R.	   F.	   Doolittle.	   1982.	   A	   simple	   method	   for	   displaying	   the	   hydropathic	   character	   of	   a	   protein.	   J	  
Mol	  Biol	  157:105-­‐32.	  
Licitra,	  B.	  N.,	  J.	  K.	  Millet,	  A.	  D.	  Regan,	  B.	  S.	  Hamilton,	  V.	  Rinaldi,	  G.	  E.	  Duhamel,	  and	  G.	  R.	  Whittaker.	  
2013.	   Mutation	   in	   spike	   protein	   cleavage	   site	   and	   pathogenesis	   of	   feline	   coronavirus.	   Emerg.	   Infect.	   Dis.	  
19:1066-­‐1073.	  
Pedersen,	  N.	  C.	  2009.	  A	  review	  of	  feline	  infectious	  peritonitis	  virus	  infection:	  1963-­‐2008.	  J	  Feline	  Med	  Surg	  
11:225-­‐58.	  
6	  

Mutations	  in	  feline	  coronavirus	  spike	  protein	  cleavage-­activation	  sites	  in	  cats	  with	  FIP	  

21.	  
22.	  
23.	  
24.	  
25.	  
26.	  
27.	  
28.	  
29.	  
30.	  
31.	  
32.	  
33.	  
34.	  
35.	  
36.	  
37.	  

Pedersen,	   N.	   C.	   2014.	   An	   update	   on	   feline	   infectious	   peritonitis:	   Diagnostics	   and	   therapeutics.	   Vet	   J.
201:133-­‐41.	  
Pedersen,	  N.	  C.	  2014.	  An	  update	  on	  feline	  infectious	  peritonitis:	  Virology	  and	  immunopathogenesis.	  Vet	  J.	  
201:123-­‐32.	  
Pedersen,	  N.	  C.,	  J.	  F.	  Boyle,	  K.	  Floyd,	  A.	  Fudge,	  and	  J.	  Barker.	  1981.	  An	  enteric	  coronavirus	  infection	  of	  
cats	  and	  its	  relationship	  to	  feline	  infectious	  peritonitis.	  Am	  J	  Vet	  Res	  42:368-­‐77.	  
Pedersen,	   N.	   C.,	   H.	   Liu,	   K.	   A.	   Dodd,	   and	   P.	   A.	   Pesavento.	   2009.	   Significance	   of	   coronavirus	   mutants	   in	  
feces	  and	  diseased	  tissues	  of	  cats	  suffering	  from	  feline	  infectious	  peritonitis.	  Viruses	  1:166-­‐84.	  
Perdue,	  M.	  L.	  2008.	  Molecular	  Determinants	  of	  Pathogenesis	  for	  Avian	  Influenza	  Viruses,	  p.	  23-­‐41.	  In	  D.	  E.	  
Swayne	  (ed.),	  Avian	  Influenza.	  Blackwell,	  Ames,	  Iowa.	  
Poland,	  A.	  M.,	  H.	  Vennema,	  J.	  E.	  Foley,	  and	  N.	  C.	  Pedersen.	  1996.	  Two	  related	  strains	  of	  feline	  infectious	  
peritonitis	  virus	  isolated	  from	  immunocompromised	  cats	  infected	  with	  a	  feline	  enteric	  coronavirus.	  J	  Clin	  
Microbiol	  34:3180-­‐4.	  
Polgar,	  L.	  1989.	  Mechanisms	  of	  Protease	  Action.	  CRC-­‐Press.	  
Porter,	   E.,	   S.	   Tasker,	   M.	   J.	   Day,	   R.	   Harley,	   A.	   Kipar,	   S.	   G.	   Siddell,	   and	   C.	   R.	   Helps.	   2014.	   Amino	   acid	  
changes	  in	  the	  spike	  protein	  of	  feline	  coronavirus	  correlate	  with	  systemic	  spread	  of	  virus	  from	  the	  intestine	  
and	  not	  with	  feline	  infectious	  peritonitis.	  Vet	  Res	  45:49.	  
Richards,	   F.	   M.	   1974.	   The	   interpretation	   of	   protein	   structures:	   total	   volume,	   group	   volume	   distributions	  
and	  packing	  density.	  J	  Mol	  Biol	  82:1-­‐14.	  
Rottier,	  P.	  J.,	  K.	  Nakamura,	  P.	  Schellen,	  H.	  Volders,	  and	  B.	  J.	  Haijema.	  2005.	  Acquisition	  of	  macrophage	  
tropism	   during	   the	   pathogenesis	   of	   feline	   infectious	   peritonitis	   is	   determined	   by	   mutations	   in	   the	   feline	  
coronavirus	  spike	  protein.	  J	  Virol	  79:14122-­‐30.	  
Salemi,	   M.,	   W.	   M.	   Fitch,	   M.	   Ciccozzi,	   M.	   J.	   Ruiz-­Alvarez,	   G.	   Rezza,	   and	   M.	   J.	   Lewis.	   2004.	   Severe	   acute	  
respiratory	  syndrome	  coronavirus	  sequence	  characteristics	  and	  evolutionary	  rate	  estimate	  from	  maximum	  
likelihood	  analysis.	  J	  Virol	  78:1602-­‐3.	  
Seidah,	  N.	  G.,	  and	  A.	  Prat.	  2012.	  The	  biology	  and	  therapeutic	  targeting	  of	  the	  proprotein	  convertases.	  Nat	  
Rev	  Drug	  Discov	  11:367-­‐83.	  
Shiba,	  N.,	  K.	  Maeda,	  H.	  Kato,	  M.	  Mochizuki,	  and	  H.	  Iwata.	  2007.	  Differentiation	  of	  feline	  coronavirus	  type	  
I	  and	  II	  infections	  by	  virus	  neutralization	  test.	  Vet	  Microbiol	  124:348-­‐52.	  
Taylor,	  W.	  R.	  1986.	  The	  classification	  of	  amino	  acid	  conservation.	  J	  Theor	  Biol	  119:205-­‐18.	  
Thomas,	   G.	   2002.	   Furin	   at	   the	   cutting	   edge:	   From	   protein	   traffic	   to	   embryogenesis	   and	   disease.	   Nat	   Rev	  
Mol	  Cell	  Biol	  3:753-­‐766.	  
Vennema,	  H.,	  A.	  Poland,	  J.	  Foley,	  and	  N.	  C.	  Pedersen.	  1998.	  Feline	  infectious	  peritonitis	  viruses	  arise	  by	  
mutation	  from	  endemic	  feline	  enteric	  coronaviruses.	  Virology	  243:150-­‐7.	  
Vijgen,	  L.,	  E.	  Keyaerts,	  E.	  Moes,	  I.	  Thoelen,	  E.	  Wollants,	  P.	  Lemey,	  A.	  M.	  Vandamme,	  and	  M.	  Van	  Ranst.	  
2005.	   Complete	   genomic	   sequence	   of	   human	   coronavirus	   OC43:	   molecular	   clock	   analysis	   suggests	   a	  
relatively	  recent	  zoonotic	  coronavirus	  transmission	  event.	  J	  Virol	  79:1595-­‐604.	  

	  
	  

	  

7	  

TABLE	  1	  	  	  	  
Amino	  acid	  sequences	  in	  the	  S1/S2	  and	  S2'	  regions	  of	  the	  FCoV	  spike	  obtained	  from	  fecal	  samples	  from	  heathly	  cats.	  	  The	  ten	  
amino	   acids	   comprising	   the	   predicted	   proteolytic	   cleavage	   sites	   are	   in	   bold,	   with	   modifications	   to	   these	   residues	   colored	  
(green	  =	  modification	  to	  non-­‐core	  residue).	  	  
	  
Cat ID
Sample
S1/S2
S2'
150
Feces
TSSRRSRRSTTE
HSIGKRSAVED
106
Feces
TQSRRSRRSYPD
PTIGKRSAVED
110
Feces
TQTRRSRRSTSE
PRIGKRSAVED
111
Feces
THSRRARRSTVE
PRIGKRSAVED
125
Feces
TQSRRARRSTVE
PTIGKRSAVED
126
Feces
TQSRRSRRSASS
PTIGKRSAVED
128
Feces
THSRRARRSTVE
PTIGKRSAVED
129
Feces
TQSRRSRRSTSD
PTIGKRSAVED
131
Feces
TQSRRSRRSASN
PTIGKRSAVED
132
Feces
TQSRRSRRSAPE
PRIGKRSAVED
135
Feces
TQSRRARRSLPA
PRIGKRSAVED
136
Feces
TQSRRSRRSVVE
PQIGKRSAVED
137
Feces
TSSRRSRRSTPE
HSIGKRSAVED
138
Feces
TQSRRSRRSVAE
PTIGKRSAVED
140
Feces
TQSRRSRRSVVE
PTIGKRSAVED
141
Feces
TQSRRSRRSVVE
PQIGKRSAVED
142
Feces
THSRRARRSTVE
PTIGKRSAVED
143
Feces
TSSRRARRSSVE
PTIGKRSAVED
144
Feces
TQSRRSRRSASM
PTIGKRSAVED
146
Feces
THSRRARRSTVE
PKIGKRSAVED
149
Feces
TSSRRSRRSTPE
HSIGKRSAVED
150
Feces
VNHTSSRRSRRSTTET
HSIGKRSAVED
152
Feces
THSRRSRRSNSD
PRIGKRSAVED
153
Feces
PHSRRSRRSTNY
PTIGKRSAVED
not determined
155
Feces
TQSGRSRRSASD
160
Feces
NHTHSKRSRRSTSN
PTIGKRSAVED
167
Feces
THSKRSRRSTSN
PTIGKRSAVED
234.1
Feces
THTRRSRRSAPV
PTIGKRSAVED
246
Feces
NHTQSKRSRRSAPH
PKIGKRSAVED
304
Feces
THTRRSRRSAPV
PTIGKRSAVED
307
Feces
THTRRSRRSAPV
PTIGKRSAVED
308
Feces
NHTHTRRSRRSAPI
PKIGKRSAVED
308
Feces
THTRRSRRSAPI
PTIGKRSAVED
310
Feces
THTRRSRRSAPA
PTIGKRSAVED
313
Feces
HARTRRSRRSAPV
PKIGKRSAVED
NTQSRRARRSASDS
PQIGKRSAVED
349
Feces
352
Feces
NTQSRRARRSASDS
PQIGKRSAVED
PTIGKRSAVED
277.2
Feces
NHTQSRRSRRSTSDFV
NHTQSRRVRRSVQESVQ
PTIGKRSAIED
278
Feces
BL1
Feces
THTRRSRRSAPA
PTIGKRSAVED
BL10
Feces
THTRRSRRSAPV
PTIGKRSAVED
BL11
Feces
THTRRSRRSAPV
PTIGKRSAVED
BL12
Feces
THTRRSRRSAPV
PTIGKRSAVED
BL13
Feces
THTRRSRRSAPV
PTIGKRSAVED
BL2
Feces
THTRRSRRSAPA
PTIGKRSAVED
BL3
Feces
THTRRSRRSAPA
PTIGKRSAVED
BL4
Feces
THTRRSRRSAPA
PTIGKRSAVED

BL5
BL6
BL7
BL8
BL9
FECV-4582
FECV-4594
FECV-FCA4597
FECV-FCA4606
	  
	  
	  
	  

Feces
Feces
Feces
Feces
Feces
Feces
Feces
Feces
Feces

THTRRSRRSAPV
THTRRSRRSAPI
THTRRSRRSAPI
THTRRSRRSAPI
THTRRSRRSAPA
TQQRRSRRSTSD
TQQRRSRRSTSD
TQQRRSRRSTSD
TQQRRSRRSTSD

PTIGKRSAVED
PTIGKRSAVED
PTIGKRSAVED
PTIGKRSAVED
PTIGKRSAVED
PTIGKRSAVED
PTIGKRSAVED
PTIGKRSAVED
PTIGKRSAVED

TABLE	  2	  	  	  	  	  
Amino	  acid	  sequences	  in	  the	  S1/S2	  and	  S2'	  regions	  of	  the	  FCoV	  spike	  obtained	  from	  tissue	  and	  body	  fluid	  samples	  from	  cats	  
diagnosed	  with	  FIP.	  	  The	  ten	  amino	  acids	  comprising	  the	  predicted	  proteolytic	  cleavage	  sites	  are	  in	  bold,	  with	  modification	  to	  
these	  residues	  colored	  (red	  and	  blue	  =	  modification	  to	  core	  residue,	  green	  and	  violet	  =	  modification	  to	  non-­‐core	  residue).	  ND	  =	  
not	  determined.	  
	  
Tissue
S1/S2
S2'
Cat ID
not determined
Mesentery
TSSRRSPRSTLD
129308
not determined
Lower Gut
TSSRRSLRSTVR
Blood
TQSRRARSSASD
PRIGERSAVED
147
Ascites
TSSRRSRRPTTE
HSIGKRSAVED
148
not determined
151643-08
Heart
TQFRRARRSAVR
not determined
Spleen
TQFRRSRRSTPG
not determined
Liver
TQFRRSRRSTVR
Ascites
NHTQPRRARRSVSELV
PPSIGKRSAVED
157
Liver
NHTQPRRARRSVSELV
PPSIGKRSAVEDLLFN
Spleen
NHTQPRRARRSVSELV
PSIGKRSAVEDLLF
Spleen
NHTQPRRARRSVSELV
PPSIGKRSAVEDLLFN
Ascites
NHTSSRRSRMSTPET
PPSIGKRSAVED
159
Ascites
NHTQSRRSRRATSNP
PTTGKRSAVED
162
Urinary Discharge
NHTQSRRSRMSTSDS
PPRVGKSSAIED
163
not determined
Brain
HTHPRRSRGSTIETV
166
170
Ascites
TQSRRSRRSTSD
PTIGKRSAVED
not determined
Liver
PTIGKRSAVED
Lung
NHTQSRRSRRSTSDFVT
PPTIGKRSAVEDLLFN
Ascites
NHTQSRGSRRSTSD
PTIGKRSAVED
179
Chest Fluid
NHTQSRRSRRSTSD
PPTIGKRSAVED
181
Liver
VNHTQSRRSRRSTSD
PTIGKRSAVEDLLFN
Lung
VNHTQSRRSRRSTSD
PTIGKRSAVEDLLFN
Spleen
VNHTQSRRSRRSTSDF
PTIGKRSAVEDLLFN
Ascites
NHTQSRSSRRSTPV
PPSIGKRSAVED
182
Thoracic Fluid
NHTQSRRSRGSTSD
PPTIGKRSAVED
192
not
determined
Spinal Cord
NHTQSKTAPRGTSDSV
195
not determined
NHTQSKTAPRATSDS
Ascites
NHTHSKRARWSTSD
PRIGMRSAIED
197
not determined
Kidney
THSRRSLRSAPV
Liver
NHTHSKRARWSTSDS
PPRIGMRSAIEDLLFN
not determined
Lung.1
THTRRSLRSAPD
Lung.2
NHTHSKRARWSTSDS
PPRIGMRSAIEDLLFN
Omentum
NHTHSKRARWSTSDS
PPRIGMRSAIEDLLFN
not determined
Small Intestine.1
THSRRSRRSASD
Small Intestine.2
NHTHSKRARWSTSDS
PPRIGMRSAIEDLLFN
Spleen
NHTHSKRARWSTSDS
PPRIGMRSAIEDLLFN
Ascites
NHTHLRRSRRSTPE
RVGKRSAVED
211
Ascites
NHTQSKSARRSTSD
PRIGKRSAIED
215
not determined
Liver
TQSKSARRSTSD
232
not determined
Lung
TQSKSARRSTSD
Spinal Fluid
NHTQSKSARRSTSD
PRIGKRSAIED
not determined
Kidney
THTRRSLRSAPV
234
Lung
NHTHTRRSLRSAPVA
PPTIGKRSAVEDLLF
Blood
NHTQSKTARRSTSD
PRVGKSSAIED
239
Brain
NHTQSKTARRSTSDS
PPRVGKSSAIED
not determined
NHTQSKTALRSTSDS
Cerebellum
NHTQSKTALRSTSDSVI
PPRVGKSSAIED
not determined
NHTQSKTARRSTSDSVI
Cerebrum
NHTQSKTARRSTSDS
PPRVGKSSAIED

241
244

245
256
259
261

350
77

08-153990

N04-93
N05-48
N05-110
N07-95
D04-397

D06-327
429
430
	  
	  
	  
	  
	  	  	  	  

Kidney.1
Kidney.2
Spleen
Ascites
Mesentery
Mesenteric lymph
node
Spinal Fluid
Ascites
Brain
Lung
Liver
Small Intestine
Spleen
Kidney
Lung
Kidney
Cerebellum.1
Cerebellum.2
Kidney
Cerebrum
Brain stem
Cerebellum
Kidney
Cerebrum
Cerebellum
Mesenteric lymph
node
Cerebellum
Cerebrum
Spleen
Mesentric lymph
node
Spleen
Mesentery
Omentum
Omentum

THTRRSLRSAPV
NHTQSKTARRSTSDS
NHTQSKTARRSTSD
NYTHSRRSLSSTPE
HSRRASTSTSN

not determined
PPRVGKSSAIED
PPRVGKSSAIEDLLF
PRIGKRSAVED
not determined

TQSRRASTSTSN

not determined

NHTQSRRSRRSKSN
not determined
NHTHSKRARWSTSD
THTQSKSARRSTSDSVI
TQSKSARRSTSD
TQSRRMRRSTSN
TRSRRMRRSTSN
TQSRRMRRSTSN
NHTSARRSRRSASEII
VNHTSARRSRRSASEI
THSRRSRMSTQN
THSRRSLRSTQN
THSRRSRRSTQN
TQPRRARMSVPE
TQPRRARMSVPE
TQPRRAPMSVPE
TQPRRARMSVPE
THLRRSHRSTSE
TLTGRSHRSTSE
TQSRSSRRSTSD

PTVGKSSAVED
TVGKRSAVED
PRIGMRSAIED
KRSAIED
not determined
not determined
not determined
not determined
PTIGKRSAVED
PTIGKRSAVED
not determined
not determined
not determined
not determined
PTIGMRSAVED
PTIGMRSAVED
PTIGMRSAVED
not determined
not determined
not determined

TQTKRSRRSTPQ

PTIGKRSAVED

TQTKRSRRSTPA
THTRKTRRSIAD
TQSRRSRRSTVD

not determined
not determined
not determined

TQSRRSRRLTSN

not determined

THSRRSRGSAPN
THSRRSRGSAPN
TSSRSSRRSTSE
SQSRRSRSSTSE

not determined
not determined
SRIGERSAVED
PRVGKRSAVED

TABLE	  3	  	  	  	  	  
Amino	  acid	  sequences	  in	  the	  S1/S2	  and	  S2'	  regions	  of	  the	  FCoV	  spike	  obtained	  from	  fecal	  	  samples	  from	  cats	  diagnosed	  with	  
FIP.	  	  The	  ten	  animo	  acids	  comprising	  the	  predicted	  proteolytic	  cleavage	  sites	  are	  in	  bold,	  with	  modification	  to	  these	  residues	  
colored	  (green	  =	  modification	  to	  non-­‐core	  residue).	  

	  
	  

Cat ID

Sample

S1/S2

S2'

107

Feces

TTSRRPRRSDPA

PTIGKRSAVED

108

Feces

QSSRRSRRSTSD

PTIGKRSAVED

145

Feces

THSRRARRSTVE

PKIGKRSAVED

148
215

Feces

TSSRRSRRSTTE

PKIGKRSAVED

Feces

THARRSRRSTPE

PRIGKRSAIED

251

Feces

TQSKRARRSTSD

PRIGKRSAIED

347

Feces

TRSRRSRRSTLEP

PRVGKRSAVED

352

Feces

TQSRRARRSASDS

PQIGKRSAVED

TABLE	  4	  	  	  	  	  
Amino	  acid	  sequences	  in	  the	  S1/S2	  and	  S2'	  regions	  of	  the	  FCoV	  spike	  obtained	  from	  Chang	  et	  al.	  and	  databases.	  	  The	  ten	  amino	  
acids	  comprising	  the	  predicted	  proteolytic	  cleavage	  sites	  are	  in	  bold,	  with	  modification	  to	  these	  residues	  colored	  (red	  and	  blue	  
=	  modifiation	  to	  core	  residue,	  green	  =	  modification	  to	  non-­‐core	  residue).	  Modifications	  that	  are	  not	  expected	  to	  be	  functionally	  
relevent	  are	  shown	  in	  gray.	  n/a	  -­‐	  not	  applicable/unknown.	  
	  
FECV
Name

Tissue

UU2

feces

SRRSRRS

RRS

UU7

feces

SRRARRS

KRS

UU10

feces

SKRSRRS

KRS

UU11

feces

SKRSRRS

KRS

UU18

feces

PRRSRRS

KRS

UU19

feces

SRRSRRS

TRS

UU20

feces

SRRSRRS

KRS

UU22

feces

SRRSRRS

RRS

UU23

feces

SRRSRRS

RRS

UU31

feces

SRRSRRS

KRS

n/a

PRRSRRS

S1/S2

S2’

DATABASE
SEQUENCE
RM

KRS

FIPV
Name

Tissue

UU3

n/a

UU4

n/a

UU5

n/a

UU8

n/a

UU9

n/a

UU15

n/a

UU16

n/a

UU17

n/a

UU21

n/a

UU24

n/a

UU30

n/a

S1/S2
SRRSRRS
SRSARGS
SRRSRGS
SRRSRRS
SRRSRRL
LRRSRRP
PRGSRRS
SRRSRRS
SRRSRWS
SRRSRSS
LRRSRRS

S2’
MRS
MRS
KRS
KRS
KRS
KRS
MRS
VRS
MRS
KRS
KRS

DATABASE SEQUENCES
Black/TN406

Liver

FCoV C1Je

Jejunu
m

Q66951_9ALPC
(KU-2)
Q8JVL1_9ALPC
(Black/TN406)
Q8JVL2_9ALPC
(UCD1)

	  

n/a
n/a
n/a

AKRSRRP
PRQSRRS
ARRSRSS
AKRSRRP
SRRSRGS

VRS
KRS
KRS
ARS
QRS

FIGURE	  1.	  	  
Visual	  representation	  of	  amino	  acid	  properties	  in	  the	  S1/S2	  and	  S2’	  cleavage	  sites	  for	  FECV	  and	  FIPV.	  The	  Y-­‐axis	  is	  the	  Van	  der	  
Waals	   volume	   (Å3),	   and	   the	   X-­‐axis	   is	   the	   hydropathy	   index	   (unitless).	   The	   data	   point	   size	   corresponds	   to	   the	   frequency	   of	  
occurrence.	  Note	  that	  for	  FIPV,	  the	  frequency	  of	  occurrence	  is	  based	  on	  all	  samples	  collected	  and	  not	  just	  the	  number	  of	  FIP	  
cats	  sampled.	  The	  table/legend	  summarizes	  all	  amino	  acid	  properties	  and	  color	  code.	  	  
	  

	  

